Common use of Enforcement of Patents and Trademarks Clause in Contracts

Enforcement of Patents and Trademarks. (a) If either party considers that any Patent Rights in the Field and in the Territory are being infringed by a third party’s activities, it shall notify the other party and provide it with any evidence of such infringement that is reasonably available. Upon written notice to Glycomed, ParinGenix shall have the first right, but not the obligation, at its own expense to attempt to remove such infringement by commercially appropriate steps, including filing an infringement suit or taking other similar action. If required by law in order for ParinGenix to prosecute such suit, Glycomed shall join such suit as a party, at ParinGenix’ expense; and, in such instance, Glycomed shall be represented by counsel chosen by ParinGenix. In the event ParinGenix fails to take commercially appropriate steps with respect to an infringement that is likely to have a material adverse effect on the sale of a Licensed Product in the Territory within three (3) months following notice of such infringement, Glycomed shall have the right to do so at Glycomed’s expense; provided, however, that if ParinGenix has commenced negotiations with an alleged infringer for discontinuance of such infringement within such three-month period, ParinGenix shall have an additional six (6) months to conclude its negotiations before Glycomed may bring suit for such. The party not enforcing the applicable Patent Rights shall provide reasonable assistance to the other party, including providing access to relevant documents and other evidence and making its employees available at reasonable business hours, subject to the enforcing party’s reimbursement of any reasonable out-of-pocket expenses incurred by the non-enforcing party. To ensure that no rights of Glycomed are compromised in any such action, ParinGenix shall not settle any such claim, or enter into any settlement agreement that admits that any third party product does not infringe the Patent Rights or that any Patent Rights are invalid or unenforceable without Glycomed’s prior written consent, which consent shall not be unreasonably withheld, delayed, denied or conditioned. (b) Any amounts recovered by either party pursuant to Section 12.2(a), whether by settlement or judgment, shall be used to reimburse the parties for their reasonable out-of-pocket expenses in making such recovery (which amounts shall be allocated pro rata if insufficient to cover the totality of such expenses), with any remainder being retained by or paid to ParinGenix; provided, however, that ParinGenix shall pay to Glycomed an amount of monies or cash equivalents received from any alleged infringer (net of any amounts applied towards expense and cost reimbursement as set forth above) equivalent to royalties which Glycomed would have received on Net Sales.

Appears in 1 contract

Samples: Exclusive Patent License Agreement (Ligand Pharmaceuticals Inc)

AutoNDA by SimpleDocs

Enforcement of Patents and Trademarks. (a) If either party considers that any Licensor Patents, Myriad Patent, or Joint Patent Rights in the Field and in the Territory are is being infringed by a third party’s Third Party's activities, it shall notify the other party and provide it with any evidence of such infringement that is reasonably available. Upon written notice to GlycomedLicensor, ParinGenix Myriad shall have the first right, but not the obligation, at its own expense to attempt to remove such infringement by commercially appropriate steps, including filing an infringement suit or taking other similar action. If required by law in order for ParinGenix Myriad to prosecute such suit, Glycomed Licensor shall join such suit as a party, at ParinGenix’ Myriad's expense; and, . Licensor agrees to use reasonable efforts to obtain any consents required by Third Parties owning Licensor Patents licensed to Licensor in such instance, Glycomed shall be represented by counsel chosen by ParinGenixorder for Myriad to conduct suits thereunder. In the event ParinGenix Myriad fails to take commercially appropriate steps with respect to an infringement that is likely to have a material adverse effect on the sale of a the Licensed Product in the Territory within three (3) months following notice of such infringement, Glycomed Licensor shall have the right to do so at Glycomed’s Licensor's expense; provided, however, that if ParinGenix -------- ------- Myriad has commenced negotiations with an alleged infringer for discontinuance of such infringement within such three-month period, ParinGenix Myriad shall have an additional six (6) months to conclude its negotiations before Glycomed Licensor may bring suit for suchsuch infringement and provided further that Myriad shall not be -------- ------- required to enforce any infringed Licensor Patents or Joint Patent against more than one entity or in more than one country at any one time. The party not enforcing the applicable Licensor Patents or Joint Patent Rights shall provide reasonable assistance to the other party, including providing access to relevant documents and other evidence and making its employees available at reasonable business hours, subject to the enforcing party’s 's reimbursement of any reasonable out-of-pocket expenses incurred by the non-enforcing party. To ensure that no rights of Glycomed Licensor are compromised in any such action, ParinGenix Myriad shall not settle any such claim, or enter into any settlement agreement that admits that any third party Third Party product does not infringe the Patent Rights Licensed Patents or that any Licensed Patent Rights are is invalid or unenforceable without Glycomed’s prior written Licensor's consent, which consent shall not be unreasonably withheld, delayed, denied or conditioned. (b) Any amounts recovered by either party pursuant to Section 12.2(a5.3(a), whether by settlement or judgment, shall be used to reimburse the parties for their reasonable out-of-pocket expenses in making such recovery (which amounts shall be allocated pro rata if insufficient to cover the totality of such expenses), with any remainder being retained by or paid to ParinGenixMyriad; provided, -------- however, that ParinGenix Myriad shall pay to Glycomed Licensor an amount of monies or cash ------- equivalents received from any alleged infringer (net of any amounts applied towards expense and cost reimbursement as set forth above) equivalent to royalties which Glycomed Licensor would have received on Net Salesif such alleged infringer had been a Sublicensee. (c) Except as otherwise provided by the provisions of Section 5.3(a), each party shall retain the sole and exclusive right to enforce its rights under any Patents and its rights to any Trademarks against all infringers at its sole cost and expense.

Appears in 1 contract

Samples: License Agreement (Myriad Genetics Inc)

AutoNDA by SimpleDocs

Enforcement of Patents and Trademarks. (a) If either party considers that any Licensor Patents, Myriad Patent, or Joint Patent Rights in the Field and in the Territory are is being infringed by a third partyThird Party’s activities, it shall notify the other party and provide it with any evidence of such infringement that is reasonably available. Upon written notice to GlycomedLicensor, ParinGenix Myriad shall have the first right, but not the obligation, at its own expense to attempt to remove such infringement by commercially appropriate steps, including filing an infringement suit or taking other similar action. If required by law in order for ParinGenix Myriad to prosecute such suit, Glycomed Licensor shall join such suit as a party, at ParinGenix’ Myriad’s expense; and, . Licensor agrees to use reasonable efforts to obtain any consents required by Third Parties owning Licensor Patents licensed to Licensor in such instance, Glycomed shall be represented by counsel chosen by ParinGenixorder for Myriad to conduct suits thereunder. In the event ParinGenix Myriad fails to take commercially appropriate steps with respect to an infringement that is likely to have a material adverse effect on the sale of a the Licensed Product in the Territory within three (3) months following notice of such infringement, Glycomed Licensor shall have the right to do so at GlycomedLicensor’s expense; provided, however, that if ParinGenix Myriad has commenced negotiations with an alleged infringer for discontinuance of such infringement within such three-month period, ParinGenix Myriad shall have an additional six (6) months to conclude its negotiations before Glycomed Licensor may bring suit for suchsuch infringement and provided further that Myriad shall not be required to enforce any infringed Licensor Patents or Joint Patent against more than one entity or in more than one country at any one time. The party not enforcing the applicable Licensor Patents or Joint Patent Rights shall provide reasonable assistance to the other party, including providing access to relevant documents and other evidence and making its employees available at reasonable business hours, subject to the enforcing party’s reimbursement of any reasonable out-of-pocket expenses incurred by the non-enforcing party. To ensure that no rights of Glycomed Licensor are compromised in any such action, ParinGenix Myriad shall not settle any such claim, or enter into any settlement agreement that admits that any third party Third Party product does not infringe the Patent Rights Licensed Patents or that any Licensed Patent Rights are is invalid or unenforceable without GlycomedLicensor’s prior written consent, which consent shall not be unreasonably withheld, delayed, denied or conditioned. (b) Any amounts recovered by either party pursuant to Section 12.2(a5.3(a), whether by settlement or judgment, shall be used to reimburse the parties for their reasonable out-of-pocket expenses in making such recovery (which amounts shall be allocated pro rata if insufficient to cover the totality of such expenses), with any remainder being retained by or paid to ParinGenixMyriad; provided, however, that ParinGenix Myriad shall pay to Glycomed Licensor an amount of monies or cash equivalents received from any alleged infringer (net of any amounts applied towards expense and cost reimbursement as set forth above) equivalent to royalties which Glycomed Licensor would have received on Net Salesif such alleged infringer had been a Sublicensee. (c) Except as otherwise provided by the provisions of Section 5.3(a), each party shall retain the sole and exclusive right to enforce its rights under any Patents and its rights to any Trademarks against all infringers at its sole cost and expense.

Appears in 1 contract

Samples: License and Collaboration Agreement (Myriad Genetics Inc)

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!